Clinical Trial Update: Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating temozolomide plus bevacizumab for metastatic melanoma involving the central nervous system has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Avastin (bevacizumab)
• Temodar (Temozolomide)

Snippet

Sponsor: Mt. Sinai Medical Center, Miami | Conditions: Melanoma | Phase 2 | Status: COMPLETED